Breast Cancer Trials
45th Annual Scientific Meeting

In association with the Japanese Clinical Oncology Group and the Korean Breast Cancer Study Group

Count Every Second Until #BCT2024

Days
Hours
Minutes
Seconds

Welcome

Welcome to the official website for the Breast Cancer Trials (BCT) 2024 Annual Scientific Meeting (ASM).

This is the 45th year of the conference, which will be held in association with the Japanese Clinical Oncology Group (JCOG) and the Korean Breast Cancer Study Group (KBCSG), and is the foremost meeting for breast cancer clinical trials research in Australasia.

Hosting a number of internationally renowned guest speakers including key BCT researchers, delegates include leading Australian and New Zealand medical practitioners and clinicians, and clinical trials management personnel. The full and extensive program will include two days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research and other research developments. The ASM will also include abstracts, debates, and is followed by a two-day trainee and early-career weekend. The theme for the ASM will be International Collaboration in Breast Cancer Trials, and we look forward to colleagues joining the meeting.

BCT is a world leading clinical trials research organisation, dedicated to finding new and better treatments and prevention strategies for people affected by this disease. Our research program involves multicentre national and international clinical trials and brings together more than 926 researchers in 114 institutions throughout Australia and New Zealand. BCT has contributed to over 1,230 peer-reviewed publications and more than 17,170 women have participated in our breast cancer clinical trials.

We look forward to an in-person meeting, offering the opportunity for us all to connect in Queensland, Australia. For up-to-date information on COVID-19 in Australia, including travel requirements, click here. 

The Breast Cancer Trials ASM is not open to the general public to attend.

Play Video

乳がん臨床試験グループ Breast Cancer Trials (BCT) 2024 年次学術会議 (ASM) の公式ウェブサイトへアクセスいただき 有難うございます!

今回で45回目となるこの会議は、日本の臨床腫瘍グループ(JCOG)と韓国の乳がん研究グループ(KBCSG)との連携で開催される、オーストラリアにおける乳がん臨床試験研究の会議です。

主要なBCT研究者を含む多数の国際的に著名なゲストスピーカーを迎え、オーストラリアとニュージーランドの主要な医師や臨床医、臨床試験管理担当者が参加します。会議では 最新の乳がんの臨床試験レビュー、新しいプロトコルの議論、将来の臨床試験の検討、その他の多くの研究開発をカバーする セッションが2日間にわたって開催されます。 また、会議の後日間の研修生ワークショップも開催予定です。

BCT は世界をリードする臨床試験研究グループであり、乳がんに罹患している人々のための新しくより良い治療法と予防戦略を見つけることに専念しています。 研究プログラムには、国内および国際的な多施設臨床試験が含まれており、オーストラリアとニュージーランド全土の 114 施設の 926 名を超える研究者が参加しています。 BCT  1,230 を超える論文や出版物を発表しており、17,170 人を超える乳がん患者が臨床試験に参加しています。

私たちは、2024年にオーストラリアのクイーンズランドで次回会議を開催いたします。 皆様のご参加をお待ちしています。

渡航要件など、オーストラリアの新型コロナウイルス感染症に関する最新情報については、ここをクリックしてください。

Breast Cancer Trials (BCT) 2024 연례 과학 회의(ASM) 공식 웹사이트에 오신 것을 환영합니다.

이번 학회는 일본임상종양연구회(JCOG)와 한국유방암연구회(KBCSG)과 공동으로 개최하는 45년차 학술대회로, 오세아니아 내 유방암 임상시험 연구를 위한 최대 규모의 학술대회입니다.

주요 BCT 연구자들을 포함하여 국제적으로 유명한 다수의 초청 연사를 주최하는 대표단에는 호주 및 뉴질랜드의 주요 의료 종사자 및 임상의사, 임상 시험 관리 인력이 포함됩니다. 풍성하고 광범위한 프로그램에는 유방암 임상 시험에 대한 시기적절한 리뷰, 새로운 프로토콜에 대한 토론, 향후 임상 시험 연구 및 기타 연구 개발을 다루는 이틀간의 과학 세션이 포함될 것입니다. ASM에는 초록, 토론도 포함되며, 이틀 간의 연수생 워크숍이 이어집니다.

BCT 는 이 질병의 영향을 받는 사람들을 위한 새롭고 더 나은 치료법과 예방 전략을 찾는 데 전념하는 세계적인 임상 시험 연구 기관입니다. 우리의 연구 프로그램에는 다기관 국내 및 국제 임상 시험이 포함되며 호주와 뉴질랜드 전역의 114개 기관에서 926명 이상의 연구자들이 참여합니다. BCT는 1,230개 이상의 전문가검토 간행물에 기여했으며 17,170명 이상의 여성이 유방암 임상 시험에 참여했습니다.

우리는 호주 퀸즈랜드에서 우리 모두가 연결될 수 있는 기회를 제공하는  대면 회의를 기대하고 있습니다. 여행 요건을 포함하여 호주의 코로나19에 대한 최신 정보를 보려면 여기를 클릭하세요.

Breast Cancer Trials (BCT) 연례 과학 회의에 일반 대중은 참석할 수 없습니다.

Guest Speakers

Michael Gnant

International Guest Speaker

Andrew Tutt

International Guest Speaker

Elinor Sawyer

International Guest Speaker

Our Sponsors

If you are interested in becoming a sponsor at Breast Cancer Trials 45th Annual Scientific Meeting, please email asm@bctrials.org.au.

Platinum Sponsor

Diamond Sponsor

Bronze Sponsor

Symposium Sponsor

Wednesday Lunch Symposium and Friday Breakfast Symposium Sponsor:
Thursday Lunch Symposium Sponsor:
Thursday Breakfast Symposium and Conference Dinner Sponsor:

Grants and Awards

The Alan Coates Award

This award recognises a member of BCT who has made an outstanding contribution to the BCT's clinical trials research program.

The Robert Sutherland Award

This award recognises a Translational Researcher and their achievements and contributions to improved patient outcomes and is open to BCT members and non-members worldwide.

The John Collins Fellow Medal

This award was established to encourage potential academic Breast Cancer Surgeons to become involved in clinical trials research.

Education Travel Grants

These grants recognise Full Members of BCT who are unable to access institutional or other funding to attend the Annual Scientific Meeting.

Wanting to get involved?

There are many benefits to becoming a member of Breast Cancer Trials (BCT), including reduced registration at the ASM each year. Please submit your membership application before May 16, 2024 to be eligible to receive a discounted registration. Any memberships received after this date will not be eligible for discounted registration rates for the 2024 ASM. 

There are two BCT membership categories: Full Member and Affiliate Member. A Full Member is deemed by the Board to be or will be directly involved in the conduct of the BCT research program. An Affiliate Member is deemed by the Board to have an interest in and awareness of BCT, and its’ research activities, but who is not involved in the conduct of the BCT’s research program.

If you would like more information or to apply for a membership, visit our website here. 

2024 Clinical Fellow Dr Jenna Dean.